Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.

作者: Jinhua Li , Yu Bo Yang Sun , Weiyi Chen , Jinjin Fan , Songhui Li

DOI: 10.15252/EMBR.201948781

关键词:

摘要: Diabetic nephropathy (DN) is the leading cause of end‐stage kidney disease. TGF‐β1/Smad3 signalling plays a major pathological role in DN; however, the contribution of Smad4 has not been examined. Smad4 depletion in the kidney using anti‐Smad4 locked nucleic acid halted progressive podocyte damage and glomerulosclerosis in mouse type 2 DN, suggesting a pathogenic role of Smad4 in podocytes. Smad4 is upregulated in human and mouse podocytes during DN. Conditional Smad4 deletion in podocytes protects mice …

参考文章(70)
Maynard E. Pullman, Gladys C. Monroy, A NATURALLY OCCURRING INHIBITOR OF MITOCHONDRIAL ADENOSINE TRIPHOSPHATASE. Journal of Biological Chemistry. ,vol. 238, pp. 3762- 3769 ,(1963) , 10.1016/S0021-9258(19)75338-1
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Yu BY Sun, Xinli Qu, Victor Howard, Lie Dai, Xiaoyun Jiang, Yi Ren, Ping Fu, Victor G Puelles, David J Nikolic-Paterson, Georgina Caruana, John F Bertram, Mark W Sleeman, Jinhua Li, None, Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance Kidney International. ,vol. 88, pp. 286- 298 ,(2015) , 10.1038/KI.2015.121
J.R. Williamson, R. Steinman, K. Coll, T.L. Rich, Energetics of citrulline synthesis by rat liver mitochondria. Journal of Biological Chemistry. ,vol. 256, pp. 7287- 7297 ,(1981) , 10.1016/S0021-9258(19)68960-X
Javier García-Bermúdez, María Sánchez-Aragó, Beatriz Soldevilla, Araceli del Arco, Cristina Nuevo-Tapioles, José M. Cuezva, PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H+-ATP Synthase Cell Reports. ,vol. 12, pp. 2143- 2155 ,(2015) , 10.1016/J.CELREP.2015.08.052
Lijuan Pang, Tao Qiu, Xu Cao, Mei Wan, Apoptotic role of TGF-β mediated by Smad4 mitochondria translocation and cytochrome c oxidase subunit II interaction. Experimental Cell Research. ,vol. 317, pp. 1608- 1620 ,(2011) , 10.1016/J.YEXCR.2011.02.004
Yuan Zhu, James A Richardson, Luis F Parada, Jonathan M Graff, Smad3 Mutant Mice Develop Metastatic Colorectal Cancer Cell. ,vol. 94, pp. 703- 714 ,(1998) , 10.1016/S0092-8674(00)81730-4
L Shen, L Zhi, W Hu, M X Wu, IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation Cell Death & Differentiation. ,vol. 16, pp. 603- 612 ,(2009) , 10.1038/CDD.2008.184
Yves Gorin, Rita C. Cavaglieri, Khaled Khazim, Doug-Yoon Lee, Francesca Bruno, Sachin Thakur, Paolo Fanti, Cédric Szyndralewiez, Jeffrey L. Barnes, Karen Block, Hanna E. Abboud, Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes American Journal of Physiology-renal Physiology. ,vol. 308, ,(2015) , 10.1152/AJPRENAL.00396.2014
Jill D. Dombrauckas, Bernard D. Santarsiero, Andrew D. Mesecar, Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry. ,vol. 44, pp. 9417- 9429 ,(2005) , 10.1021/BI0474923